Diagnósticos, próteses, vacinas, genómica: a medicina que ganha anos de vida.
A medicina que ganha anos de vida: rastreios assistidos por IA que examinam milhões de doentes, vacinas de nova geração, uma genómica que passa da sequenciação ao tratamento, próteses e implantes que devolvem capacidades perdidas. A secção segue os ensaios clínicos concluídos, as autorizações de introdução no mercado, as implantações hospitalares — o momento em que uma tecnologia deixa de ser uma publicação para se tornar um cuidado.
Os números mandam: coortes, taxas de deteção, mortalidade evitada, custos. Cobrimos de bom grado os sistemas de saúde que implantam em grande escala — a Índia, o Brasil, o Sudeste Asiático — porque as tecnologias frugais costumam provar-se aí antes de chegarem a outros lugares. Cada artigo apoia-se no ensaio, na autorização ou no estudo que o funda, e cita-os.
- Johnson & Johnson’s Imaavy is cleared for patients aged 12 and older with warm autoimmune hemolytic anemia.
The TEAMSS initiative worked with 160 clinicians at 27 pediatric clinics across 18 states.
The circuit links the amygdala and prefrontal cortex, two regions involved in emotion and decision-making.
Northwestern researchers tested more than 1,900 NAT10 variants in one proliferation assay.
L-32 targets PTPN22, a protein that restrains immune activity.
The system estimates both tumor volume and where its segmentation may be wrong.
Penn State researchers tested 12 guinea fowl, six of which carried weights equal to 4% of body weight during growth.
At one year, 23.6% of thrombectomy patients were functionally independent, versus 6.8% receiving medical care.
The cells carry CHL1, a gene not normally found on healthy-lung fibroblasts.
The combination pushed tumor-cell DNA damage beyond repair, triggering programmed cell death.
Researchers at National Taiwan University built the first spatial map of ovarian clear cell carcinoma.
The changes differ between infectious and noninfectious forms of Trypanosoma cruzi.
The STAR-TREC phase 2/3 trial enrolled more than 500 patients across five European countries.
- The regimen alternated 24 hours of fasting with 24 hours of unrestricted feeding for 38 days.
Peter Mac researchers identified four proteins pancreatic cancer cells rely on to grow and survive.
Georgia State's method aligns brain timescales before comparing network signal strength.
A Cornell team activated macrophages after targeted therapy to recruit immune cells against resistant melanoma cells.
The recordings came from 23 patients during deep brain stimulation surgery.